Aligos Therapeutics (ALGS)

• Market cap: $42.8M
• 1 day: -0.43%
• 5 days: 2.96%
• 1 month: -3.87%
• 3 months: -37.27%
• 6 months: -38.06%
• Year to date: -23.88%
• 1 year: -33.24%
• 5 years: -98.88%
• 10 years: -98.13%
• Sector: Healthcare
• Industry: Biotechnology

About: Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

Employees: 70